Vistagen Therapeutics CEO Shawn Singh's 2023 pay falls 49% to $600K
Vistagen Therapeutics reports 2023 executive compensation
By ExecPay News
Published: July 28, 2023
Vistagen Therapeutics reported fiscal year 2023 executive compensation information on July 28, 2023.
In 2023, three executives at Vistagen Therapeutics received on average a compensation package of $529K, a 44% decrease compared to previous year.
Average pay of disclosed executives at Vistagen Therapeutics
Shawn K. Singh, Chief Executive Officer, received $600K in total, which decreased by 49% compared to 2022. 100% of Singh's compensation, or $600K, was in salary.
Reid G. Adler, General Counsel, received a compensation package of $552K. 67% of the compensation package, or $372K, was in salary.
Jerrold D. Dotson, Chief Financial Officer, earned $434K in 2023, a 39% decrease compared to previous year.
Vistagen Therapeutics' fiscal year ends on March 31.
Related executives
You may also like
Source: SEC filing on July 28, 2023.